Medicare Enrolled

Dr. Stuart Shafer, MD

Neurology · Vero Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1040 37TH PL STE 201, Vero Beach, FL 32960
7724927051
In practice since 2005 (20 years)
NPI: 1003818816 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shafer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shafer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shafer

Dr. Stuart Shafer is a neurology in Vero Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Shafer performed 17,971 Medicare services across 3,351 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shafer received a total of $151,215 from 71 pharmaceutical and/or device companies across 772 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shafer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 6% volume in FL$ $151,215 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17,971
Medicare services
Top 6% in FL for neurology
3,351
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~899 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit13,020$5$12
Office visit, established patient (30-39 min)1,049$95$224
Office visit, established patient (20-29 min)423$65$153
Needle measurement of electrical activity in arm or leg muscles, limited study389$50$123
Injection, methylprednisolone sodium succinate, up to 125 mg380$4$19
New patient office visit (45-59 min)296$123$348
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional270$18$41
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less259$51$219
EEG, extended monitoring255$345$866
Needle measurement of electrical activity in arm or leg muscles, complete study251$79$190
Administration of psychological or neuropsychological test by technician, first 30 minutes239$27$60
Measurement of brain wave activity (eeg), awake and drowsy182$300$757
Nerve conduction, 9-10 studies156$166$486
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour149$17$110
Injection of additional new drug or substance into vein132$13$68
Nerve conduction, 13 or more studies104$226$622
Drug injection, under skin or into muscle98$10$56
Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report86$65$170
Evaluation of neuropsychological test, first hour56$105$260
Administration of chemotherapy into vein, each additional hour42$23$130
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face38$132$390
Administration of chemotherapy into vein, 1 hour or less38$102$600
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and32$41$112
Measurement of nerve conduction using visual stimulation testing with report27$49$271
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
78.9% medium
18.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$151,215
Total received (2018-2024)
Avg $21,602/year across 7 years
Top 4% in FL for neurology
71
Companies
772
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$115,344 (76.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25,174 (16.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,697 (7.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,946
2023
$2,346
2022
$10,006
2021
$16,357
2020
$18,047
2019
$56,203
2018
$46,310

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$48,425
Genentech USA, Inc.
$44,241
Biogen, Inc.
$13,066
Novartis Pharmaceuticals Corporation
$11,217
Mallinckrodt Hospital Products Inc.
$10,912
Mallinckrodt LLC
$7,851
Mallinckrodt Enterprises LLC
$6,914
EMD Serono, Inc.
$1,335
Teva Pharmaceuticals USA, Inc.
$512
Lilly USA, LLC
$510
AbbVie Inc.
$380
PFIZER INC.
$372
Sunovion Pharmaceuticals Inc.
$370
Alexion Pharmaceuticals, Inc.
$336
Celgene Corporation
$309
UCB, Inc.
$234
Horizon Therapeutics plc
$219
Amneal Pharmaceuticals LLC
$214
MDD US Operations, LLC
$184
Acorda Therapeutics, Inc
$172
Lundbeck LLC
$169
ABBVIE INC.
$164
ARGENX US, INC.
$140
Allergan, Inc.
$137
Stryker Corporation
$134
Supernus Pharmaceuticals, Inc.
$127
Avanir Pharmaceuticals, Inc.
$124
Janssen Pharmaceuticals, Inc
$122
SK Life Science, Inc.
$115
Merz Pharmaceuticals, LLC
$105
Otsuka America Pharmaceutical, Inc.
$100
Janssen Research & Development, LLC
$100
Adamas Pharmaceuticals, Inc.
$100
Amgen Inc.
$96
Eisai Inc.
$95
ACADIA Pharmaceuticals Inc
$88
TG Therapeutics, Inc.
$87
BIOTRONIK INC.
$85
US WorldMeds, LLC
$83
Sumitomo Pharma America, Inc.
$77
Biohaven Pharmaceuticals, Inc.
$76
UPSHER-SMITH LABORATORIES LLC
$73
Biohaven Pharmaceutical Holding Company Ltd.
$73
Takeda Pharmaceuticals U.S.A., Inc.
$68
Allergan Inc.
$61
Kyowa Kirin, Inc.
$60
Grifols USA, LLC
$56
E.R. Squibb & Sons, L.L.C.
$56
Upsher-Smith Laboratories LLC
$56
Alnylam Pharmaceuticals Inc.
$55
Eli Lilly and Company
$55
Neurocrine Biosciences, Inc.
$51
TG THERAPEUTICS, INC.
$44
ARBOR PHARMACEUTICALS, INC.
$41
CATALYST PHARMACEUTICALS, INC.
$38
MITSUBISHI TANABE PHARMA AMERICA, INC.
$37
Corium, LLC
$28
Almatica Pharma LLC
$27
Xeris Pharmaceuticals, Inc.
$25
Axsome Therapeutics, Inc.
$24
Boston Scientific Corporation
$22
ANI Pharmaceuticals, Inc.
$21
Impax Laboratories, Inc.
$20
Neurelis, Inc.
$19
CSL Behring
$19
SI-BONE, Inc.
$18
Exeltis, USA Inc.
$17
Bio Products Laboratory USA, Inc.
$15
InSightec,Inc
$15
Nevro Corp.
$14
Avion Pharmaceuticals
$13
Top 3 companies account for 69.9% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BIOMONITOR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · COLOGUARD DNA CAPTURE REAGENTS · COPAXONE · CREXONT · DUOPA · Dhivy · EMGALITY · Exablate · FIRDAPSE · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gammaplex · Gamunex-C · General - DBS · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KRYSTEXXA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Omnia · Ongentys · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREVO · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection · Zilbrysq · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in FL.

Equivalent to $841 per 100 Medicare services performed
Looking for a neurology in Vero Beach?
Compare neurologys in the Vero Beach area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
20
Per 100K population
12.2
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shafer is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (speaking/promotional, top 4%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shafer experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Shafer performed 13,020 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shafer receive payments from pharmaceutical companies?
Yes. Dr. Shafer received a total of $151,215 from 71 companies across 772 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shafer's costs compare to other neurologys in Vero Beach?
Dr. Shafer's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shafer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →